Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| OrthoPediatrics Corp. to Present at FDA Conference on Pediatric Devices | ||
| By: Nasdaq / GlobeNewswire - 10 Aug 2018 | Back to overview list |
|
WARSAW, Ind., Aug. 10, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to participate in the Pediatric Medical Device Development Public Meeting, organized by the U.S. Food & Drug Administration (“FDA”). The conference will take place at the FDA’s White Oak Campus in suburban Washington D.C. on August 13-14, 2018. OrthoPediatrics’ President & CEO, Mark Throdahl, will present on the “Small Company Business Model”, during which he will describe the Company’s business model and evolution. He will then participate on an Expert Panel discussion titled, “The Next 10 Years: Toward a Modern Medical Device Ecosystem for Adults and Children.” In addition, OrthoPediatrics’ Chief Medical Office, Dr. Peter F. Armstrong, will address the conference during a “Public Comment Presentation” on pediatric medical device development. Mr. Throdahl commented, “We are honored to participate in this year’s event as the only orthopedic company that has successfully built a business exclusively focused on pediatric devices. We applaud and support the FDA’s efforts to stimulate the development of pediatric specific medical devices, and we look forward to continued collaboration with the organization.” About OrthoPediatrics Corp. Investor Contacts |
||
|
||
 | Back to overview list | |